Colon Cancer Diagnosis and Therapy Vol. 3

Inbunden, Engelska, 2022

AvDhananjay Shukla,Naveen Kumar Vishvakarma,Ganji Purnachandra Nagaraju

3 059 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment.

Produktinformation

Utgivningsdatum2022-02-15
Mått155 x 235 x 31 mm
Vikt875 g
FormatInbunden
SpråkEngelska
Antal sidor460
FörlagSpringer Nature Switzerland AG
ISBN9783030727017

Tillhör följande kategorier

Onkologi inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin

Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Nagaraju obtained his MSc and PhD, both in biotechnology from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. Dr. Nagaraju received his D.Sc. from Berhampur University in Berhampur, Odisha, India. Dr. Nagaraju's research focuses on translational research in gastrointestinal malignancies. He has published over 90 research papers in highly respected international journals and has presented more than 50 abstracts at various national and international conferences. He is author and editor of several books. Dr. Nagaraju is an editorial board member of several internationally recognized academic journals, and is an associate member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He is a member of the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative andComparative Biology (SICB), the Science Advisory Board, The RNA Society and the American Association of Cancer Research (AACR).Dr. Dhananjay Shukla is an Assistant Professor in the Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A Central University) in India. Dr. Shukla received his PhD in Biotechnology from Jamia Hamdard University. He is a member of the Indian Immunological Society and Indian Science Congress. He has presented and been invited to lecture at a number of national meetings in India. Dr. Naveen Kumar Vishvakarma is an Assistant Professor in the Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A Central University) in India. Dr. Vishvakarma received his PhD in Biotechnology from Banaras Hindu University. He has written a number of book chapters and been invited to lecture at a dozens of national meetings in India.

Chapter 1. Role of chemokines in colorectal cancer.- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy.- Chapter 3. Epigenetic regulation of colorectal cancer (CRC).- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis.- Chapter 5. Chemoresistance in colon malignancies.- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer.- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting.- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer.- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer.- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer.- Chapter 11. Prevention and management of colon cancer by nutritional intervention.- Chapter 12. Development of RNA based medicine for colorectal cancer.- Chapter 13. Role offood additives and intestinal microflora in colorectal cancer.- Chapter 14. Probiotics in colon cancer.- Chapter 15. Bacterial cancer therapy.- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer.- Chapter 17. Cyanobacterial secondary metabolite.- Chapter 18. Clinical significance of genetic variants in colon cancer.